Table 1. Demography of patients enrolled.
Ashwagandha | Placebo | ANOVA | ||||||
Mean | SD | 95% C.I. | Mean | SD | 95% C.I. | F | p | |
Intent-to-treat (ITT) dataset (n = 60) | ||||||||
N | 40 | 20 | ||||||
Age (yrs.) | 38.83 | 5.00 | 37.23 - 40.42 | 40.00 | 6.21 | 37.09 - 42.90 | 0.626 | 0.432 |
BMI (kg/sq.m) | 26.91 | 3.42 | 25.81 - 28.00 | 25.89 | 6.02 | 23.07 - 28.71 | 0.695 | 0.408 |
Per-protocol (PP) dataset (n = 48) | ||||||||
N | 39 | 19 | ||||||
Age (yrs.) | 38.97 | 4.97 | 37.36 - 40.59 | 40.05 | 6.37 | 36.98 - 43.12 | 0.498 | 0.483 |
BMI (kg/sq.m) | 26.87 | 3.46 | 25.75 - 28.00 | 25.28 | 5.50 | 22.62 - 27.93 | 1.834 | 0.181 |
No. | % | No. | % | p | ||||
Gender (M/F) | ||||||||
ITT dataset | 31/9 | 77.5%/22.5% | 16/4 | 80.0%/20.0% | 0.8261 | |||
PP dataset | 31/8 | 79.5%/20.5% | 4 | 78.9%/21.1% | 0.9263 |